glp-1 and gip receptor agonist Mechanisms of action therapeutic applications of and dual GIP/GLP-1 agonists Dual GIP/GLP-1 receptor agonists: New

Description

proved GLP-1 receptor activation by inducing the cAMP/PKA pathway in macrophages inhibits atherosclerosis through regulation of inflammatory process

So we rolled up our sleeves and dug into the actual science

At the cellular level, GLP-1 receptor activation appears to reduce the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)

For example, if youre taking insulin or sulfonylureas (both medications for diabetes), liraglutide can increase your risk for low blood sugar, says Chichak

2 GLP-1 RAs reduce major adverse cardiovascular events (MACE), including acute myocardial infarction, stroke, and mortality, in patients with multiple cardiovascular risk factors